Probing the epigenome: interview with Dr Matthew Fuchter
As part of our focus on epigenetic drug discovery, MedChemNet spoke to Dr Matthew Fuchter (Imperial College London, UK) about his work in the field, including his perspective on the potential of epigenetic research in anti-cancer and anti-infective research.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>